Title : Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models.

Pub. Date : 2004 Dec

PMID : 15596048






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ZD6474 is a novel, orally available inhibitor of vascular endothelial growth factor (VEGF) receptor-2 (KDR) tyrosine kinase, with additional activity against epidermal growth factor receptor (EGFR) tyrosine kinase. vandetanib kinase insert domain receptor Homo sapiens
2 ZD6474 is a novel, orally available inhibitor of vascular endothelial growth factor (VEGF) receptor-2 (KDR) tyrosine kinase, with additional activity against epidermal growth factor receptor (EGFR) tyrosine kinase. vandetanib kinase insert domain receptor Homo sapiens